Nuclear Medicine: Page 30

PET reveals triple threat behind Alzheimer's dementia

By Will Morton

PET imaging has shown for the first time how a triple threat of brain activity drives dementia in Alzheimer's disease patients -- and researchers created a visual map that lights up the culprit in action. Study details were published August 26 in Nature Medicine.

August 30, 2021

NorthStar wins $37M DOE award for Mo-99 production

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) Nuclear Security Administration has bestowed a $37 million award to NorthStar Medical Radioisotopes for the production of molybdenum-99 (Mo-99).

August 29, 2021

Iotron, CIIC to produce radioisotope Cu-67

By AuntMinnie.com staff writers

Iotron Medical and Canadian Isotope Innovations (CIIC) will produce the radioisotope copper-67 (Cu-67) for new cancer therapies.

August 24, 2021

Telix works with Merck on cancer therapies

By AuntMinnie.com staff writers

Telix Pharmaceuticals is entering into a collaboration with Merck for research studies on the combination of Merck's DNA damage response inhibitor molecules with Telix's therapeutic radiotracers.

August 19, 2021

New SPECT tracer detects aggressive breast cancer

By Will Morton

A new SPECT tracer based on technetium-99m is safe in patients and can detect metastatic breast cancer -- in a few cases, better than biopsies can, according to a study published August 12 in the Journal of Nuclear Medicine.

August 15, 2021

PET recommended over bone scintigraphy in pediatric sarcoma

By Will Morton

PET imaging is more effective than bone scintigraphy for detecting metastatic disease in children with soft-tissue cancer, according to a study published online August 9 in the European Journal of Cancer.

August 12, 2021

FDG-PET/CT predicts severity of COVID-19 infection

By Will Morton

FDG-PET/CT imaging in patients diagnosed with COVID-19 is associated with a higher risk of symptomatic infection and hospitalization, which may help predict disease severity, according to a study published August 8 in Clinical Imaging.

August 10, 2021

Q BioMed signs Canadian distributor for Strontium89

By AuntMinnie.com staff writers

Biotech company Q BioMed has signed an exclusive distribution agreement for its Strontium89 therapeutic radiopharmaceutical with Canadian distributor isoSolutions Marketing & Management.

August 9, 2021

GE set to supply iodine-123 to NorthStar

By AuntMinnie.com staff writers

GE Healthcare has inked an exclusive manufacturing and distribution agreement with NorthStar Medical Radioisotopes to manufacture and distribute iodine-123 capsules in the U.S.

August 2, 2021

ImaginAb signs new agreement with Boehringer Ingelheim

By AuntMinnie.com staff writers

ImaginAb has signed a new license agreement to supply its ImmunoPET radiotracer to Boehringer Ingelheim.

July 22, 2021

International Isotopes snaps up remaining RadQual shares

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes has purchased all remaining shares in its subsidiary RadQual, completing a transaction that began in 2017.

July 11, 2021

FDG-PET identifies biomarkers in dementia with Lewy bodies

By Will Morton

FDG-PET can identify whether mild cognitive impairment is associated with dementia with Lewy bodies or with Alzheimer's disease, two neurodegenerative conditions that can be indistinguishable in later stages, according to a study published July 4 in NeuroImage: Clinical.

July 7, 2021

Previous Page

Page 30 of 438

Next Page